Sectors

The corporate-backed coding education platform secured $35.3m in funding as its business receives a boost from the coronavirus lockdown.

GV led a series B round for Digits that was disclosed as it publicly launched its business expenditure analysis software, four months after its series A.

The retail group returned to take part in a series B round that will find the expansion of chickpea-based protein developer InnovoPro's production capacity.

Digital payment provider Stripe raised an extension to its series G round backed by Alphabet. The round is the latest in the payment tech space, which we have seen grow in the past decade.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

CAS Star has led a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The payment automation software producer received another $128m for a Mastercard-backed round that lifted its overall funding past $1.1bn.

GV, AbbVie Ventures and NS Investment have contributed to a series B round for the oncology drug developer, which has now raised a total of $103m.

The HLB-led group owns nearly half of vaccine product developer Immunomic Therapeutics following a $61.3m commitment this year.

Partners Innovation Fund joined Syncona to provide $20m for the neurological disease drug developer's series A round, which is sized at up to $77m.